Intervention not reported
PTB (< 37 w) ‐ Repeat cones versus No Treatment · women with known obstetric outcomes
It is very uncertain whether the intervention changes PTB (< 37 w) ‐ Repeat cones versus No Treatment (very low certainty).
1 finding from 1 review
Intervention not reported
PTB (< 37 w) ‐ Depth ≤ 10 mm to 12 mm versus No Treatment · women with known obstetric outcomes
It is very uncertain whether the intervention changes PTB (< 37 w) ‐ Depth ≤ 10 mm to 12 mm versus No Treatment (very low certainty).
1 finding from 1 review
Intervention not reported
PTB (< 37 w) ‐ PTB (< 37 w) ‐ Depth ≥10 mm to 12 mm versus No Treatment · women with known obstetric outcomes
The intervention may leads to higher PTB (< 37 w) ‐ PTB (< 37 w) ‐ Depth ≥10 mm to 12 mm versus No… (low certainty).
1 finding from 1 review
Intervention not reported
PTB (< 37w) ‐ PTB (<37w) ‐ Depth ≥15 to 17mm versus No Treatment · women with known obstetric outcomes
It is very uncertain whether the intervention changes PTB (< 37w) ‐ PTB (<37w) ‐ Depth ≥15 to 17mm versus No Treatment (very low certainty).
1 finding from 1 review
Intervention not reported
PTB (< 37 w) ‐ PTB (< 37 w) ‐ Depth ≥ 20 mm versus No Treatment · women with known obstetric outcomes
It is very uncertain whether the intervention changes PTB (< 37 w) ‐ PTB (< 37 w) ‐ Depth ≥ 20 mm versus No Treatment (very low certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality at 2 days ‐ immediate treatment · patients with acute myocardial infarction1
The intervention leads to lower all‐cause mortality at 2 days ‐ immediate treatment (high certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality at 10 days‐ short‐term treatment · patients with acute myocardial infarction1
The intervention leads to lower all‐cause mortality at 10 days‐ short‐term treatment (high certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality at 2 days ‐ immediate treatment · acute myocardial infarction1
The intervention showed no clear difference in all‐cause mortality at 2 days ‐ immediate treatment (high certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality at 10 days ‐ short‐term treatment · acute myocardial infarction1
The intervention leads to lower all‐cause mortality at 10 days ‐ short‐term treatment (high certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality at 2 days ‐ immediate treatment · patients with acute myocardial infarction1
The intervention showed no clear difference in all‐cause mortality at 2 days ‐ immediate treatment (low certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality at 10 days ‐ short‐term treatment · patients with acute myocardial infarction1
The intervention showed no clear difference in all‐cause mortality at 10 days ‐ short‐term treatment (high certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality at 2 days ‐ immediate treatment · patients with acute myocardial infarction or stroke1
It is very uncertain whether the intervention changes all‐cause mortality at 2 days ‐ immediate treatment (very low certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality at 10 days ‐ short‐term treatment · patients with acute myocardial infarction or stroke1
It is very uncertain whether the intervention changes all‐cause mortality at 10 days ‐ short‐term treatment (very low certainty).
1 finding from 1 review
Complications
It is very uncertain whether early postoperative feeding changes complications compared with standard management (very low certainty).
1 finding from 1 review
Length of hospital stay
1 finding from 1 review
All‐cause mortality
Early postoperative feeding showed no clear difference in mortality compared with standard management (low certainty).
1 finding from 1 review
Progression to psychosis ‐ by 12 months · people with psychosis
PHASE SPECIFIC TREATMENT (RISPERIDONE + CBT) + SPECIALISED TEAM probably leads to lower progression to psychosis ‐ by 6 months compared with SPECIALISED TEAM (moderate certainty).
2 findings from 1 review
Leaving the study early/ loss to · schizophrenia
Summary of findings table ‐ CBT without antipsychotics showed no clear difference in leaving the study early ‐ for any reason ‐ overall acceptability… compared with no specific treatment (low certainty).
1 finding from 1 review
Leaving the study early · people with schizophrenia with antipsychotic‐induced weight gain
Topiramate showed no clear difference in leaving the study early: for any reason compared with placebo or no treatment (low certainty).
1 finding from 1 review
Leaving the study early · people with schizophrenia with antipsychotic‐induced weight gain
It is very uncertain whether metformin changes leaving the study early: for any reason compared with placebo or no treatment (very low certainty).
1 finding from 1 review